Join
Live feed
·
INSIDERFilingvia Quantisnow
Bellerophon Therapeutics Inc. logo

SEC Form 4: Puissance Life Science Opportunities Fund VI was granted 8,189 units of Common Stock

ByQuantisnow·Wall Street's wire, on your screen.
BLPH· Bellerophon Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLPH (Bellerophon Therapeutics Inc.) and more on Quantisnow.